Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer

Clinical Significance of the Histone Deacetylase 2 (HDAC-2) Expression in Human Breast Cancer

Background/Aim: There is a strong association between malignancy and histone deacetylases (HDACs). Histone deacetylase inhibitors (HDACIs) are now being tested as antitumor agents in various clinical trials. We aimed to assess the clinical importance of HDAC-2 in breast cancer (BC). Materials and Me...

Full description

Bibliographic Details
Main Authors: Nikolaos Garmpis, Christos Damaskos, Dimitrios Dimitroulis, Gregory Kouraklis, Anna Garmpi, Panagiotis Sarantis, Evangelos Koustas, Alexandros Patsouras, Iason Psilopatis, Efstathios A. Antoniou, Michail V. Karamouzis, Konstantinos Kontzoglou, Afroditi Nonni
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Journal of Personalized Medicine
Subjects:
breast
cancer
clinicopathological
deacetylase
HDAC
histone
Online Access:https://www.mdpi.com/2075-4426/12/10/1672

Internet

https://www.mdpi.com/2075-4426/12/10/1672

Similar Items